TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 11194113

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CrS, 20 g x d(‐1) of Cr)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo (P1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Creatine supplementation (CrS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (unsupplemented)
Number of subjects: 0
Study: 9481725

Group type: EXPERIMENTAL
Intervention: Polyacrylonitrile AN69 (PAN)
Number of subjects: 5

Group type: COMPARATOR
Intervention: Cuprophan (CUP)
Number of subjects: 5
Study: 2001016

Group type: EXPERIMENTAL
Intervention: Thiopental infusion
Number of subjects: 300

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 300
Study: 6390450

Group type: EXPERIMENTAL
Intervention: Phase II studies screening for activity in patients with measurable advanced disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Phase III studies aimed at controlling the recurrence rate of superficial bladder tumors
Number of subjects: 0
Study: 31462732

Group type: EXPERIMENTAL
Intervention: auto/alloSCT
Number of subjects: 199

Group type: COMPARATOR
Intervention: tandem autoSCT
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: auto/alloSCT (in patients with both del13q and del17p)
Number of subjects: 199

Group type: COMPARATOR
Intervention: tandem autoSCT (in patients with both del13q and del17p)
Number of subjects: 199
Study: 29353006

Group type: EXPERIMENTAL
Intervention: Trained participants
Number of subjects: 102

Group type: COMPARATOR
Intervention: Untrained controls (overweight and obesity)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 102
Study: 27188901

Group type: EXPERIMENTAL
Intervention: HMB (3 g · day(‐1))
Number of subjects: 13
Study: 23021204

Group type: EXPERIMENTAL
Intervention: Radium-223 (50 kBq/kg, 4 injections every 4 weeks)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Radium-223
Number of subjects: 64

Group type: COMPARATOR
Intervention: Radium-223 and Placebo
Number of subjects: 64
Study: 21346020

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for insomnia
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sleep Hygiene (SH)
Number of subjects: 40
Study: 19724041

Group type: EXPERIMENTAL
Intervention: Immediate intervention
Number of subjects: 352

Group type: COMPARATOR
Intervention: Delayed intervention
Number of subjects: 352
Study: 17023087

Group type: EXPERIMENTAL
Intervention: Prediction group with on‐screen, visual display of predicted glycemia and predicted risks of hypoglycemia
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control group without glycemic predictions
Number of subjects: 22
Study: 15240119

Group type: EXPERIMENTAL
Intervention: IA‐2A positive patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: GADA positive patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TopIIA and GADA
Number of subjects: 0
Study: 11434648

Group type: EXPERIMENTAL
Intervention: Arginine-enriched formula (6.3 g/L)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control formula (isocaloric and isonitrogenous)
Number of subjects: 37
Study: 10492101

Group type: EXPERIMENTAL
Intervention: Uterine exteriorisation during caesarean section
Number of subjects: 288

Group type: COMPARATOR
Intervention: Suture of the uterus in the abdomen (Control)
Number of subjects: 288
Study: 7851710

Group type: EXPERIMENTAL
Intervention: Fetal fibronectin (fFN) in cervicovaginal secretions
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Beta-adrenergic treatment
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Preterm rupture of membranes (PROM)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group (negative for fFN)
Number of subjects: 78
Study: 2572261

Group type: EXPERIMENTAL
Intervention: xamoterol treatment
Number of subjects: 705

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 705
Study: 61664

Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 39
Study: 31961963

Group type: EXPERIMENTAL
Intervention: Tadalafil + Mirabegron (5 mg/50 mg/day)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Tadalafil (5 mg/day)
Number of subjects: 176
Study: 30562897

Group type: EXPERIMENTAL
Intervention: FusPbx (MRI-ultrasound fusion targeted biopsy)
Number of subjects: 41

Group type: COMPARATOR
Intervention: USPbx (randomized 12-core transrectal ultrasound guided biopsy)
Number of subjects: 41
Study: 28448250

Group type: EXPERIMENTAL
Intervention: Veggie Van (VV) program
Number of subjects: 201

Group type: EXPERIMENTAL
Intervention: Recruitment strategies (site screener, interest forms, marketing materials, site liaisons)
Number of subjects: 201
Study: 25466951

Group type: EXPERIMENTAL
Intervention: High-protein low-carbohydrate (HPLC) diet (30% protein, 35% carbohydrate, 35% fat)
Number of subjects: 32

Group type: COMPARATOR
Intervention: High-carbohydrate low-protein (HCLP) diet (5% protein, 60% carbohydrate, 35% fat)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-protein low-carbohydrate (HPLC) diet
Number of subjects: 32

Group type: COMPARATOR
Intervention: High-carbohydrate low-protein (HCLP) diet
Number of subjects: 32
Study: 23684374

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided infraclavicular block (IB)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Ultrasound-guided axillary block (AB)
Number of subjects: 82
Study: 20835873

Group type: EXPERIMENTAL
Intervention: Transdermal granisetron (GTDS), one patch for 7 days
Number of subjects: 641

Group type: COMPARATOR
Intervention: Oral granisetron, 2 mg/day for 3-5 days
Number of subjects: 641
Study: 19234005

Group type: EXPERIMENTAL
Intervention: Mobile video telephony (VT) guidance
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-video telephony (non-VT) guidance
Number of subjects: 0
Study: 16102936

Group type: EXPERIMENTAL
Intervention: Dynamic exercise
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Mental stress
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 12601675

Group type: EXPERIMENTAL
Intervention: WS(R) 1340 (90 mg peppermint oil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WS(R) 1520 (50 mg caraway oil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WS(R) 1340
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WS(R) 1520
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrophobic phase (control)
Number of subjects: 0
Study: 10864082

Group type: EXPERIMENTAL
Intervention: Hand exercise (intermittent squeezing of a hand-sized ball) during contrast material delivery
Number of subjects: 80

Group type: COMPARATOR
Intervention: No hand exercise (control group)
Number of subjects: 80
Study: 9173811

Group type: EXPERIMENTAL
Intervention: 5% human albumin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 10% hydroxyethyl starch (HAES-steril)
Number of subjects: 40
Study: 7968752

Group type: EXPERIMENTAL
Intervention: Streptokinase (SK)
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: Recombinant tissue plasminogen activator (tPA)
Number of subjects: 776

Group type: EXPERIMENTAL
Intervention: Time trade-off question
Number of subjects: 776
Study: 3295037

Group type: EXPERIMENTAL
Intervention: Calcium lactate gluconate (40 mmol of elemental calcium/day)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study: 30077640

Group type: EXPERIMENTAL
Intervention: Pemafibrate (0.4 mg/d, twice daily for 4 weeks)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (for 4 weeks)
Number of subjects: 33
Study: 28506475

Group type: EXPERIMENTAL
Intervention: Porcine perfused simulator (PL)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rubber tubing model (Control)
Number of subjects: 0
Study: 26632907

Group type: EXPERIMENTAL
Intervention: Transition care with established agreements on the transition procedure
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Transition care with median serum creatinine levels
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Transition care with immunosuppression levels
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Transition care with increased creatinine levels
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Transition care with biopsy proven rejection
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Transition care with graft loss due to chronic graft nephropathy
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Transition care with adherence to immunosuppression
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: Transition care with increased creatinine levels close to transfer
Number of subjects: 119
Study: 23286943

Group type: EXPERIMENTAL
Intervention: rosiglitazone
Number of subjects: 26

Group type: COMPARATOR
Intervention: glyburide
Number of subjects: 26
Study: 21264453

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporin A (CsA) 2.5 mg/kg
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Low-dose cyclosporin A (CsA)
Number of subjects: 30
Study: 18514525

Group type: EXPERIMENTAL
Intervention: Spatial constraint present
Number of subjects: 6

Group type: COMPARATOR
Intervention: No spatial constraint
Number of subjects: 6
Study: 17199455

Group type: EXPERIMENTAL
Intervention: Nicotine patch (3-month treatment with a 1-month taper)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Continued smoking (control group)
Number of subjects: 152
Study: 12590330

Group type: EXPERIMENTAL
Intervention: Closed in-line suction catheters (CISC) applied for 72 hours
Number of subjects: 23
Study: 10868348

Group type: EXPERIMENTAL
Intervention: Brief individual counseling and weekly newsletters (intervention)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Control group (n = 123)
Number of subjects: 186

Group type: EXPERIMENTAL
Intervention: Intervention group (n = 63)
Number of subjects: 186
Study: 9354072

Group type: EXPERIMENTAL
Intervention: Day case adenoidectomy
Number of subjects: 64

Group type: COMPARATOR
Intervention: In-patient adenoidectomy
Number of subjects: 64
Study: 8456052

Group type: EXPERIMENTAL
Intervention: Transrectal microwave hyperthermia of the prostate
Number of subjects: 54
Study: 3935013

Group type: EXPERIMENTAL
Intervention: Education program regarding asthma and asthma medications during four monthly visits
Number of subjects: 31

Group type: COMPARATOR
Intervention: Noneducation group
Number of subjects: 31
Study: 30126103

Group type: EXPERIMENTAL
Intervention: IEPalm
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: IEStear
Number of subjects: 85

Group type: COMPARATOR
Intervention: NatPO
Number of subjects: 85
Study: 27040451

Group type: COMPARATOR
Intervention: CABG alone
Number of subjects: 301

Group type: EXPERIMENTAL
Intervention: CABG plus mitral-valve repair
Number of subjects: 301
Study: 24886555

Group type: EXPERIMENTAL
Intervention: Face-to-face guided self-help
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Email guided self-help
Number of subjects: 51

Group type: COMPARATOR
Intervention: Delayed treatment control
Number of subjects: 51
Study: 22906794

Group type: EXPERIMENTAL
Intervention: Experimental arm (n = 18) - shown detailed PSG data, including graphic data from PSG prior to prescription of CPAP
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control arm (n = 19) - shown the non‐graphic paper report of the PSG
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Overall analysis
Number of subjects: 37
Study: 20189492

Group type: COMPARATOR
Intervention: Investigational hepatitis B vaccine (spHB), 10 microg HBsAg/dose for 10-15 years age group; 20 microg HBsAg/dose for 16-45 years age group, administered in a 0, 1, 6 month schedule.
Number of subjects: 688

Group type: COMPARATOR
Intervention: Licensed control vaccine (Engerix B), administered in a 0, 1, 6 month schedule.
Number of subjects: 688
Study: 18818095

Group type: EXPERIMENTAL
Intervention: PVA particles mixed with ketoprofen
Number of subjects: 80

Group type: COMPARATOR
Intervention: Bland PVA particles
Number of subjects: 80
Study: 15993559

Group type: EXPERIMENTAL
Intervention: TPB questionnaire + formed own implementation intention
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: TPB questionnaire + researcher formed implementation intention
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: TPB questionnaire
Number of subjects: 220

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 220
Study: 12946746

Group type: EXPERIMENTAL
Intervention: Artificial Neural Network (ANN)
Number of subjects: 820

Group type: COMPARATOR
Intervention: Multivariate logistic regression analysis
Number of subjects: 820

Group type: COMPARATOR
Intervention: f/t PSA ratio
Number of subjects: 820

Group type: COMPARATOR
Intervention: PSA-TZ
Number of subjects: 820

Group type: COMPARATOR
Intervention: PSAD
Number of subjects: 820

Group type: COMPARATOR
Intervention: Total PSA
Number of subjects: 820

Group type: EXPERIMENTAL
Intervention: ANN
Number of subjects: 820

Group type: COMPARATOR
Intervention: Multivariate analysis
Number of subjects: 820
Study: 10372701

Group type: EXPERIMENTAL
Intervention: Recombinant human GH (rhGH) treatment; mean dosage 1.0 U/day for men and 1.9 U/day for women (P < 0.01)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Recombinant human GH (rhGH) treatment
Number of subjects: 33
Study: 8717465

Group type: EXPERIMENTAL
Intervention: CAB with leuprolide and flutamide
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: Orchidectomy with flutamide
Number of subjects: 1300

Group type: COMPARATOR
Intervention: Orchidectomy with placebo
Number of subjects: 1300

Group type: EXPERIMENTAL
Intervention: CAB
Number of subjects: 1300
Study: 1941495

Group type: EXPERIMENTAL
Intervention: CPC mouthrinse used as an adjunct to oral hygiene before toothbrushing
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo mouthrinse used as an adjunct to oral hygiene before toothbrushing
Number of subjects: 0
Study: 6108262

Group type: EXPERIMENTAL
Intervention: Azatadine maleate/pseudoephedrine sulfate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 30845047

Group type: EXPERIMENTAL
Intervention: TRT + RT
Number of subjects: 22

Group type: COMPARATOR
Intervention: TRT
Number of subjects: 22

Group type: COMPARATOR
Intervention: Both groups (TRT and TRT + RT)
Number of subjects: 22
Study: 28893633

Group type: EXPERIMENTAL
Intervention: Laparoscopic donor nephrectomy (LDN)
Number of subjects: 224

Group type: COMPARATOR
Intervention: Open donor nephrectomy
Number of subjects: 224
Study: 25809373

Group type: EXPERIMENTAL
Intervention: Edoxaban (60 mg for 3 months or 30 mg with increased exposure factors) + Aspirin (100 mg/d for 6 months)
Number of subjects: 203

Group type: COMPARATOR
Intervention: Clopidogrel (75 mg/d for 3 months) + Aspirin (100 mg/d for 6 months)
Number of subjects: 203
Study: 24010849

Group type: EXPERIMENTAL
Intervention: Study Group (SG) - hemodynamic therapy guided by pulse pressure variation, cardiac index trending, and mean arterial pressure.
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control Group (CG) - hemodynamic therapy at the discretion of the treating anesthesiologist.
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Study Group (SG)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 160
Study: 21504240

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol added to tiotropium (Symbicort® Turbuhaler® 320/9 μg twice daily + tiotropium 18 μg daily)
Number of subjects: 659

Group type: COMPARATOR
Intervention: Placebo added to tiotropium (tiotropium 18 μg daily)
Number of subjects: 659

Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol added to tiotropium
Number of subjects: 659
Study: 19339010

Group type: EXPERIMENTAL
Intervention: Hysterosalpingo-contrast sonography (HyCoSy)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Radiographic hysterosalpingography (HSG)
Number of subjects: 88
Study: 16455835

Group type: EXPERIMENTAL
Intervention: Therapeutic CPAP
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham-placebo (subtherapeutic CPAP)
Number of subjects: 35
Study: 14665547

Group type: EXPERIMENTAL
Intervention: Halothane
Number of subjects: 40

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 40
Study: 11544424

Group type: EXPERIMENTAL
Intervention: Daclizumab (Zenapax®, Roche Pharmaceuticals)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9175060

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided cannulation
Number of subjects: 66

Group type: COMPARATOR
Intervention: External landmark-guided technique
Number of subjects: 66
Study: 8433235

Group type: EXPERIMENTAL
Intervention: Maltodextrin-containing oral rehydration solution
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard recommended glucose
Number of subjects: 120
Study: 2891522

Group type: EXPERIMENTAL
Intervention: LH-RH treatment
Number of subjects: 60

Group type: COMPARATOR
Intervention: Surgery (control)
Number of subjects: 60
Study: 29701044

Group type: EXPERIMENTAL
Intervention: Special penetration needling
Number of subjects: 97

Group type: COMPARATOR
Intervention: Conventional penetration needling
Number of subjects: 97
Study: 26995053

Group type: EXPERIMENTAL
Intervention: Bivalirudin
Number of subjects: 2198

Group type: COMPARATOR
Intervention: No bleed
Number of subjects: 2198

Group type: COMPARATOR
Intervention: Access site bleeds (ASB)
Number of subjects: 2198

Group type: COMPARATOR
Intervention: Rest of bleeds (ROB)
Number of subjects: 2198
Study: 25335387

Group type: EXPERIMENTAL
Intervention: Magnesium deficiency correction
Number of subjects: 0

Group type: COMPARATOR
Intervention: Basic therapy without magnesium deficiency correction
Number of subjects: 0
Study: 23720246

Group type: EXPERIMENTAL
Intervention: Test formulation (ibuprofen sustained-release)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Reference formulation (ibuprofen sustained-release)
Number of subjects: 19
Study: 20873912

Group type: EXPERIMENTAL
Intervention: Interpersonal psychotherapy (IPT)
Number of subjects: 120
Study: 18773807

Group type: EXPERIMENTAL
Intervention: Bone-graft group (posterior lumbar interbody fusion with autologous iliac crest)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cage group (posterior lumbar interbody fusion with interbody fusion cage)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Bone-graft group
Number of subjects: 60

Group type: COMPARATOR
Intervention: Cage group
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 15696568

Group type: EXPERIMENTAL
Intervention: High-intensity exercise classes
Number of subjects: 300

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 300
Study: 14598996

Group type: EXPERIMENTAL
Intervention: Mexican American version of the curriculum
Number of subjects: 6035

Group type: EXPERIMENTAL
Intervention: Multicultural version of the curriculum
Number of subjects: 6035

Group type: EXPERIMENTAL
Intervention: Combined African American and European American version of the curriculum
Number of subjects: 6035

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 6035
Study: 10499756

Group type: EXPERIMENTAL
Intervention: Epidural morphine (30 microg/kg followed by 3 microg/kg/h for 3 days)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Intravenous morphine (0.05-0.1 mg/kg intraoperatively, followed by 0.02 mg/kg doses postoperatively)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups (Epidural and Intravenous)
Number of subjects: 27
Study: 8560681

Group type: EXPERIMENTAL
Intervention: Bicalutamide 50 mg monotherapy
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Bicalutamide 50 mg plus LHRH-A
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Flutamide plus LHRH-A
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Bicalutamide
Number of subjects: 3000
Study: 1298575

Group type: EXPERIMENTAL
Intervention: Educational, low‐fear intervention (pictorial diagram of periodontal disease and discussion of flossing importance)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group (brief dental examination and flossing instruction)
Number of subjects: 41
Study: 6428655

Group type: EXPERIMENTAL
Intervention: Video group (videotape)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Personal group (personal teaching)
Number of subjects: 25
Study: 31012040

Group type: EXPERIMENTAL
Intervention: IV ibuprofen (800 mg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: IV acetaminophen (1000 mg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control (100 ml saline solution)
Number of subjects: 90
Study: 31442441

Group type: EXPERIMENTAL
Intervention: Lactic-acid-containing diaphragm gel (Contragel®)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Hydroxyethylcellulose (HEC) universal placebo gel
Number of subjects: 23
Study: 28363270

Group type: EXPERIMENTAL
Intervention: Dry Needling
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cortisone Injections
Number of subjects: 0
Study: 25361992

Group type: EXPERIMENTAL
Intervention: Enzalutamide 160 mg/day
Number of subjects: 938

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 938

Group type: EXPERIMENTAL
Intervention: Enzalutamide
Number of subjects: 938
Study: 24014057

Group type: EXPERIMENTAL
Intervention: Internet-delivered cognitive behavioral therapy for insomnia (CBT-I)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 44
Study: 21844156

Group type: EXPERIMENTAL
Intervention: Ablation of grade 1 CFAE
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ablation of grade 2 CFAE
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ablation of grade 3 CFAE
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ablation of grade 4 CFAE
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ablation of grade 5 CFAE
Number of subjects: 20
Study: 19643636

Group type: EXPERIMENTAL
Intervention: CT-guided biopsy with i.v. contrast application following needle placement (group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: CT-guided biopsy after contrast enhanced CT (group 2)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups (group 1 and group 2)
Number of subjects: 60
Study: 16632812

Group type: EXPERIMENTAL
Intervention: Balloon inflation
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Distraction (pressing a rubber ball)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 75
Study: 12560782

Group type: EXPERIMENTAL
Intervention: Ertapenem 1 g once a day
Number of subjects: 633

Group type: COMPARATOR
Intervention: Piperacillin/tazobactam 3.375 g every 6 hours
Number of subjects: 633
Study: 11256724

Group type: EXPERIMENTAL
Intervention: Assertive Community Treatment (ACT)
Number of subjects: 163

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: ACT (staffed by consumers or non-consumers)
Number of subjects: 163